Drugs / SR57667B
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00285025 | Mar → Sep 2005 | Alzheimer disease | Sanofi | Completed | No outcome recorded |
| Phase 2 | NCT00285077 | Mar 2004 → Nov 2006 | Alzheimer disease | Sanofi | Completed | No outcome recorded |
| Phase 2 | NCT00220272 | Jan 2004 → Mar 2007 | Parkinson disease | Sanofi | Completed | No outcome recorded |
| Phase 2 | NCT00228150 | Jul 2003 → Apr 2006 | Parkinson disease | Sanofi | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SR57667B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00228150 ↗ |